AbbVie to Pay $21 Billion for Pharmacyclics, Maker of a Promising Cancer Drug
Thursday, March 5, 2015 - 00:40
in Mathematics & Economics
AbbVie announced that it has agreed to buy Pharmacyclics, a maker of a cancer drug that some analysts predict will eventually become one of the best-selling treatments.